RS62708B1 - Nova jedinjenja - Google Patents

Nova jedinjenja

Info

Publication number
RS62708B1
RS62708B1 RS20211543A RSP20211543A RS62708B1 RS 62708 B1 RS62708 B1 RS 62708B1 RS 20211543 A RS20211543 A RS 20211543A RS P20211543 A RSP20211543 A RS P20211543A RS 62708 B1 RS62708 B1 RS 62708B1
Authority
RS
Serbia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
RS20211543A
Other languages
English (en)
Inventor
De Francisco Esther Porras
Modesto Jesús Remuiñan-Blanco
Marilyne Bourotte
Benoit Deprez
Nicolas Willand
Original Assignee
Glaxosmithkline Ip Dev Ltd
BioVersys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59713957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS62708(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Ip Dev Ltd, BioVersys AG filed Critical Glaxosmithkline Ip Dev Ltd
Publication of RS62708B1 publication Critical patent/RS62708B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20211543A 2017-08-16 2018-08-15 Nova jedinjenja RS62708B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382569 2017-08-16
EP18752171.1A EP3668879B1 (en) 2017-08-16 2018-08-15 Novel compounds
PCT/EP2018/072143 WO2019034700A1 (en) 2017-08-16 2018-08-15 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
RS62708B1 true RS62708B1 (sr) 2022-01-31

Family

ID=59713957

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20211543A RS62708B1 (sr) 2017-08-16 2018-08-15 Nova jedinjenja

Country Status (25)

Country Link
US (1) US11254689B2 (sr)
EP (1) EP3668879B1 (sr)
JP (1) JP7171726B2 (sr)
KR (1) KR102657360B1 (sr)
CN (1) CN110997680B (sr)
AU (1) AU2018317804B2 (sr)
BR (1) BR112020003192A2 (sr)
CA (1) CA3072838A1 (sr)
CL (1) CL2020000362A1 (sr)
CO (1) CO2020001506A2 (sr)
CY (1) CY1124851T1 (sr)
DK (1) DK3668879T3 (sr)
ES (1) ES2899365T3 (sr)
HR (1) HRP20211895T1 (sr)
HU (1) HUE056928T2 (sr)
IL (1) IL272562B2 (sr)
LT (1) LT3668879T (sr)
MX (1) MX2020001808A (sr)
PL (1) PL3668879T3 (sr)
PT (1) PT3668879T (sr)
RS (1) RS62708B1 (sr)
SG (1) SG11202000988RA (sr)
SI (1) SI3668879T1 (sr)
WO (1) WO2019034700A1 (sr)
ZA (1) ZA202000585B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111184718A (zh) * 2018-11-15 2020-05-22 鲁南制药集团股份有限公司 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR041198A1 (es) * 2002-10-11 2005-05-04 Otsuka Pharma Co Ltd Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
DE102005044813A1 (de) * 2005-05-19 2007-10-04 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes

Also Published As

Publication number Publication date
WO2019034700A1 (en) 2019-02-21
IL272562B2 (en) 2023-08-01
CA3072838A1 (en) 2019-02-21
LT3668879T (lt) 2022-03-25
KR102657360B1 (ko) 2024-04-16
CN110997680B (zh) 2022-10-21
SG11202000988RA (en) 2020-03-30
BR112020003192A2 (pt) 2020-09-15
KR20200041344A (ko) 2020-04-21
PT3668879T (pt) 2021-12-02
DK3668879T3 (da) 2021-12-06
EP3668879B1 (en) 2021-09-29
US11254689B2 (en) 2022-02-22
CO2020001506A2 (es) 2020-05-29
CL2020000362A1 (es) 2020-07-10
JP7171726B2 (ja) 2022-11-15
JP2020531575A (ja) 2020-11-05
ES2899365T3 (es) 2022-03-11
EP3668879A1 (en) 2020-06-24
IL272562B1 (en) 2023-04-01
ZA202000585B (en) 2021-07-28
CN110997680A (zh) 2020-04-10
RU2020109677A3 (sr) 2021-09-28
CY1124851T1 (el) 2022-11-25
SI3668879T1 (sl) 2022-04-29
AU2018317804A1 (en) 2020-02-20
MX2020001808A (es) 2022-07-19
IL272562A (en) 2020-03-31
RU2020109677A (ru) 2021-09-16
AU2018317804B2 (en) 2021-04-22
HRP20211895T1 (hr) 2022-08-19
US20210032268A1 (en) 2021-02-04
PL3668879T3 (pl) 2022-02-21
HUE056928T2 (hu) 2022-03-28

Similar Documents

Publication Publication Date Title
IL272562A (en) new compounds
GB201720187D0 (en) Novel Compounds
GB201702947D0 (en) Novel compounds
PT3668853T (pt) Novos compostos
GB201721736D0 (en) Novel Compounds
GB201721735D0 (en) Novel Compounds
GB201721732D0 (en) Novel Compounds
GB201721731D0 (en) Novel compounds
GB201721729D0 (en) Novel compounds
GB201721727D0 (en) Novel compounds
GB201721726D0 (en) Novel compounds
GB201719720D0 (en) Novel compounds
GB201718565D0 (en) Novel compounds
GB201718564D0 (en) Novel compounds
GB201718563D0 (en) Novel compounds
GB201718561D0 (en) Novel compounds
GB201716131D0 (en) Novel compounds
GB201714699D0 (en) Novel compounds
GB201713085D0 (en) Novel compounds
GB201713083D0 (en) Novel compounds
GB201713082D0 (en) Novel compounds
GB201713079D0 (en) Novel Compounds
GB201713076D0 (en) Novel compounds
GB201711682D0 (en) Novel compounds
GB201711549D0 (en) Novel compounds